Alliancebernstein L.P. Maxcyte, Inc. Transaction History
Alliancebernstein L.P.
- $280 Billion
- Q4 2024
A detailed history of Alliancebernstein L.P. transactions in Maxcyte, Inc. stock. As of the latest transaction made, Alliancebernstein L.P. holds 85,000 shares of MXCT stock, worth $357,000. This represents 0.0% of its overall portfolio holdings.
Number of Shares
85,000
Previous 85,000
-0.0%
Holding current value
$357,000
Previous $330,000
6.97%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding MXCT
# of Institutions
126Shares Held
67.2MCall Options Held
1KPut Options Held
2K-
Cadian Capital Management, LP New York, NY8.19MShares$34.4 Million1.63% of portfolio
-
Black Rock Inc. New York, NY8.14MShares$34.2 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.43MShares$22.8 Million0.0% of portfolio
-
Vitruvian Partners LLP5.04MShares$21.2 Million18.06% of portfolio
-
Morgan Stanley New York, NY4.82MShares$20.2 Million0.0% of portfolio
About MAXCYTE, INC.
- Ticker MXCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 101,724,000
- Market Cap $427M
- Description
- MaxCyte, Inc., a global life sciences company, engages in the discovery, development, and commercialization of next-generation cell therapies. Its products include ExPERT ATx, a static electroporation instrument for small to medium scale transfection; ExPERT STx, a flow electroporation for protein production and drug development, as well as expr...